Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  van Simaeys, Dimitri ^a,b   Ló pez Colón, Dalia ^a,b   Sefah, Kwame ^a,b   Sutphen, Rebecca ^c   Jimenez, Elizabeth ^a,b   Tan, Weihong ^a,b,d  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CELL MARKER; TUMOR MARKER;

ARTICLE; CANCER CELL; CELL SURFACE; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR PROBE; OVARY CANCER; PROTEIN BINDING; TARGET CELL; UTERINE CERVIX CANCER; BINDING COMPETITION; BINDING SITE; CELL STRAIN HCT116; CELL STRAIN HT29; FEMALE; FLOW CYTOMETRY; GENETICS; HELA CELL; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; TEMPERATURE; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HCT116 CELLS; HELA CELLS; HT29 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; SELEX APTAMER TECHNIQUE; TEMPERATURE; TUMOR MARKERS, BIOLOGICAL;

EID: 78249268260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013770     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Hartge P (2010) Designing early detection programs for ovarian cancer. J Natl Cancer Inst 102: 3-4.
3. Kurman RJ, Shih IM (2010) The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory. Am J Surg Pathol.
4. Willmott LJ, Fruehauf JP (2010) Targeted therapy in ovarian cancer. J Oncol 2010: 740472.
5. Nosov V, Su F, Amneus M, Birrer M, Robins T, et al. (2009) Validation of serum biomarkers for detection of early-stage ovarian cancer. Am J Obstet Gynecol 200: 639 e631-635.
6. Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, et al. (2007) Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Gynecol Oncol 105: 404-408.
7. Munkarah A, Chatterjee M, Tainsky MA (2007) Update on ovarian cancer screening. Curr Opin Obstet Gynecol 19: 22-26.
8. Reynolds EA, Moller KA (2006) A review and an update on the screening of epithelial ovarian cancer. Curr Probl Cancer 30: 203-232.
9. Shirai T, Imanaka Y, Sekimoto M, Ishizaki T (2009) Primary chemotherapy patterns for ovarian cancer treatment in Japan. J Obstet Gynaecol Res 35: 926-934.
10. Williams TI, Toups KL, Saggese DA, Kalli KR, Cliby WA, et al. (2007) Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. J Proteome Res 6: 2936-2962.
11. Maines-Bandiera S, Woo MM, Borugian M, Molday LL, Hii T, et al. (2010) Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Int J Gynecol Cancer 20: 16-22.
12. Oaknin A, Barretina P, Perez X, Jimenez L, Velasco M, et al. (2010) CA-125 response patterns in patients with recurrent ovarian cancer treated with pegylated liposomal doxorubicin (PLD). Int J Gynecol Cancer 20: 87-91.
13. Jacobs IJ, Menon U (2004) Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics 3: 355-366.
14. Fang X, Tan W (2010) Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res 43: 48-57.
15. Lu C, Shahzad MM, Moreno-Smith M, Lin YG, Jennings NB, et al. (2010) Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther 9.
16. Ulrich H, Wrenger C (2009) Disease-specific biomarker discovery by aptamers. Cytometry A 75: 727-733.
17. Zhao Z, Xu L, Shi X, Tan W, Fang X, et al. (2009) Recognition of subtype nonsmall cell lung cancer by DNA aptamers selected from living cells. Analyst 134: 1808-1814.
18. Chen HW, Medley CD, Sefah K, Shangguan D, Tang Z, et al. (2008) Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 3: 991-1001.
19. Shangguan D, Cao Z, Meng L, Mallikaratchy P, Sefah K, et al. (2008) Cellspecific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res 7: 2133-2139.
20. Shangguan D, Cao ZC, Li Y, Tan W (2007) Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples. Clin Chem 53: 1153-1155.
21. Cerchia L, Duconge F, Pestourie C, Boulay J, Aissouni Y, et al. (2005) Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 3: e123.
22. Bing T, Yang X, Mei H, Cao Z, Shangguan D (2010) Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg Med Chem.
23. Jhaveri S, Rajendran M, Ellington AD (2000) In vitro selection of signaling aptamers. Nat Biotechnol 18: 1293-1297.
24. Tang Z, Parekh P, Turner P, Moyer RW, Tan W (2009) Generating aptamers for recognition of virus-infected cells. Clin Chem 55: 813-822.
25. Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, et al. (2008) Identification of liver cancer-specific aptamers using whole live cells. Anal Chem 80: 721-728.
26. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, et al. (2007) Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics 6: 2230-2238.
27. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, et al. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 103: 11838-11843.
28. Provencher DM, Lounis H, Champoux L, Tetrault M, Manderson EN, et al. (2000) Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim 36: 357-361.
29. Bast RC, Jr., Jacobs I, Berchuck A (1992) Malignant transformation of ovarian epithelium. J Natl Cancer Inst 84: 556-558.
30. Fitter S, James R (2005) Deconvolution of a Complex Target Using DNA Aptamers. JBC 280: 34193-34201.
31. Faca V M, Ventura A P, Fitzgibbon M P, Pereira-Faca S R et al (2008) Proteomic Analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS ONE 3: e2425.